For instance, Auronafin and disulfiram are two ROS-producing medications that have been shown in studies to increase PD-L1 expression in cancer cells, whereas other ROS-enhancing compounds (such as ethaselen, chaetocin, and metformin) tend to lower PD-L1 expression. The gene discussed is CD274; the disease is cancer.